4.3 Article

Can the two mechanisms of tumor cell killing by radiation be exploited for therapeutic gain?

期刊

JOURNAL OF RADIATION RESEARCH
卷 55, 期 1, 页码 2-9

出版社

OXFORD UNIV PRESS
DOI: 10.1093/jrr/rrt111

关键词

LQ model; tumor cell killing; TCP modeling; NTCP modeling; optimal radiotherapy

向作者/读者索取更多资源

The radiation killing of tumor cells by ionizing radiation is best described by the linear-quadratic (LQ) model. Research into the underlying mechanisms of alpha- and beta-inactivation has suggested that different molecular targets (DNA in different forms) and different microdosimetric energy deposits (spurs versus electron track-ends) are involved. Clinical protocols with fractionated doses of about 2.0 Gy/day were defined empirically, and we now know that they produce cancer cures mainly by the alpha-inactivation mechanism. Radiobiology studies indicate that alpha and beta mechanisms exhibit widely different characteristics that should be addressed upfront as clinical fractionation schemes are altered. As radiation treatments attempt to exploit the advantages of larger dose fractions over shorter treatment times, the LQ model can be used to predict iso-effective tumor cell killing and possibly iso-effective normal tissue complications. Linking best estimates of radiobiology and tumor biology parameters with tumor control probability (TCP) and normal tissue complication probability (NTCP) models will enable us to improve and optimize cancer treatment protocols, delivering no more fractions than are strictly necessary for a high therapeutic ratio.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据